CASSANDRA VORGANG: Open Payments
NPI 1588219646 · VIENNA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$260 in 11 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $7,270 · 2025 $260
Food & beverage: $260
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $63 |
| Novo Nordisk Inc | 2 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| United Therapeutics Corporation | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| PFIZER INC. | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, Wegovy, Orenitram, JARDIANCE, Kerendia, VYNDAQEL, ZEPBOUND.
Industry payments across VA — which companies pay providers there.
